MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)

Event Details

Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)

Time: December 2, 2021 at 10am to December 3, 2021 at 4pm
Location: online
Website or Map: https://www.complianceonline.…
Phone: 1-888-717-2436
Event Type: webinar
Organized By: Complianceonline
Latest Activity: Oct 4

Export to Outlook or iCal (.ics)

Event Description

This FIVE HOUR/DAY, interactive ON-LINE Seminar which provides a conduit to enhance your understanding of the Continued Process Verification, will be reviewed in detail: where does it begin; what is included; and, when does it end.

Common questions asked by the users of Process Validation include;

  • How does one integrate these two different concepts (Phase 1, 2, and 3 vs. Stages 1, 2, and 3) and where do they merge?
  • Do they exist independently of each other or do they complement each other to enhance, build and provide a product that neither alone could. Questions that may arise include where are cGMPs initiated?
  • To what extent must they be used? Since Stage 3 extends through commercial batch manufacturing, what happens to Phase 3?
  • Does it follow along or with Stage 3? Questions that exist include how one manages special situations to include viral inactivation and removal, impurity clearance, process consistency, process solution stability, endotoxin, bioburden, and other miscellaneous cell culture tests to include DNA and host cell protein.

Learning Objectives:

Why these FDA Guidance/EU Guidelines for Industry - Process Validation is so important to the pharmaceutical and biotechnology industry.

  • What FDA segments are included and excluded within the "NEW" Process Validation.
  • Where does the Process Validation commence.
  • What are the Three Stages and Where They Apply within the NEW Process Validation.
  • How Stage 1 integrates with Phase 1.
  • The Validation approaches that are included within this Guidance document.
  • The Statutory and Regulatory Requirements for Process Validation.
  • An Introduction to Phase 1 Guidance for Industry and Its Application within the "NEW" Process Validation.
  • The Phase 1 Investigational Drug Requirements -- What is and What is NOT Required.
  • General Considerations for Process Validation - Stage 2 Process Qualification.
  • Regulatory Strategies for Phase 2 and 3 and their Incorporation within Stages 1 and 2.
  • General Considerations for Process Validation - Stage 3 Continued Process Verification.
  • A Review of EU Annex 15 and its Comparison to FDA’s Process Validation Guidance.

Who Will Benefit:

Those who will benefit from this ON-LINE seminar include

  • Product Development
  • Project Management
  • Regulatory Compliance
  • Quality Assurance
  • Quality Control

Comment Wall

Comment

RSVP for Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation) to add comments!

Join MedTech I.Q.

Attending (1)

© 2021   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service